Features, pricing, ratings, and pros and cons, compared head to head.
ASPIA Third-Party Risk Management Solution is a commercial third-party risk management tool by ASPIA Infotech Pvt. Ltd.. Mitratech Prevalent is a commercial third-party risk management tool by Mitratech. Compare features, ratings, integrations, and community reviews side by side to find the best third-party risk management fit for your security stack. Independent and vendor-neutral: we never sell rankings.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
ASPIA Third-Party Risk Management Solution
Mid-market and enterprise security teams managing 50+ vendors will get the most from ASPIA Third-Party Risk Management Solution because it actually enforces contractual obligations instead of just scoring risk, which is where most platforms stop. The platform covers GV.SC supply chain risk management and real-time continuous monitoring, meaning you catch vendor drift between assessments rather than waiting for annual rescans. Skip this if you need deep API integrations with your existing GRC stack; ASPIA is strongest when you can dedicate resources to active vendor engagement and remediation workflows.
Security and compliance teams managing 50+ vendors will see immediate ROI from Mitratech Prevalent because its 800+ assessment templates eliminate months of custom questionnaire building and let you get risk scores back in weeks instead of quarters. The platform's AI-powered assessment completion cuts the manual work of chasing vendors for responses by roughly 60 percent, and continuous monitoring across cyber threats and business risks covers the full NIST supply chain risk management domain. Skip this if your vendor base is under 30 relationships or if you need deep integration with your existing GRC tools; Prevalent assumes you're buying a purpose-built TPRM system, not bolting onto what you already have.
Third-party vendor risk assessment and continuous monitoring platform
AI-powered TPRM platform for vendor risk assessment, monitoring & remediation
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing ASPIA Third-Party Risk Management Solution vs Mitratech Prevalent for your third-party risk management needs.
ASPIA Third-Party Risk Management Solution: Third-party vendor risk assessment and continuous monitoring platform. built by ASPIA Infotech Pvt. Ltd.. Core capabilities include Third-party vendor security assessments, Real-time continuous monitoring of vendor risk profiles, Automated due diligence for vendor onboarding..
Mitratech Prevalent: AI-powered TPRM platform for vendor risk assessment, monitoring & remediation. built by Mitratech. Core capabilities include Automated vendor risk assessments with 800+ templates, AI-powered assessment completion, Inherent and residual risk scoring..
Both serve the Third-Party Risk Management market but differ in approach, feature depth, and target audience.
ASPIA Third-Party Risk Management Solution differentiates with Third-party vendor security assessments, Real-time continuous monitoring of vendor risk profiles, Automated due diligence for vendor onboarding. Mitratech Prevalent differentiates with Automated vendor risk assessments with 800+ templates, AI-powered assessment completion, Inherent and residual risk scoring.
ASPIA Third-Party Risk Management Solution is developed by ASPIA Infotech Pvt. Ltd.. Mitratech Prevalent is developed by Mitratech. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
ASPIA Third-Party Risk Management Solution and Mitratech Prevalent serve similar Third-Party Risk Management use cases: both are Third-Party Risk Management tools. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox